These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9748358)

  • 1. Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study.
    Mor M; Rivara S; Silva C; Bordi F; Plazzi PV; Spadoni G; Diamantini G; Balsamini C; Tarzia G; Fraschini F; Lucini V; Nonno R; Stankov BM
    J Med Chem; 1998 Sep; 41(20):3831-44. PubMed ID: 9748358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional quantitative structure-activity relationship of melatonin receptor ligands: a comparative molecular field analysis study.
    Sicsic S; Serraz I; Andrieux J; Brémont B; Mathé-Allainmat M; Poncet A; Shen S; Langlois M
    J Med Chem; 1997 Feb; 40(5):739-48. PubMed ID: 9057860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacophoric search and 3D-QSAR comparative molecular field analysis studies on agonists of melatonin sheep receptors.
    Marot C; Chavatte P; Morin-Allory L; Viaud MC; Guillaumet G; Renard P; Lesieur D; Michel A
    J Med Chem; 1998 Nov; 41(23):4453-65. PubMed ID: 9804685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.
    Rivara S; Mor M; Silva C; Zuliani V; Vacondio F; Spadoni G; Bedini A; Tarzia G; Lucini V; Pannacci M; Fraschini F; Plazzi PV
    J Med Chem; 2003 Apr; 46(8):1429-39. PubMed ID: 12672242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformationally restrained melatonin analogues: synthesis, binding affinity for the melatonin receptor, evaluation of the biological activity, and molecular modeling study.
    Spadoni G; Balsamini C; Diamantini G; Di Giacomo B; Tarzia G; Mor M; Plazzi PV; Rivara S; Lucini V; Nonno R; Pannacci M; Fraschini F; Stankov BM
    J Med Chem; 1997 Jun; 40(13):1990-2002. PubMed ID: 9207940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.
    Mathé-Allainmat M; Gaudy F; Sicsic S; Dangy-Caye AL; Shen S; Brémont B; Benatalah Z; Langlois M; Renard P; Delagrange P
    J Med Chem; 1996 Aug; 39(16):3089-95. PubMed ID: 8759629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional quantitative structure-activity relationship study of nonsteroidal estrogen receptor ligands using the comparative molecular field analysis/cross-validated r2-guided region selection approach.
    Sadler BR; Cho SJ; Ishaq KS; Chae K; Korach KS
    J Med Chem; 1998 Jun; 41(13):2261-7. PubMed ID: 9632359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonergic properties of the (+)- and (-)-enantiomers of N-(4-methoxy-2,3-dihydro-1H-phenalen-2-yl)amide derivatives.
    Jellimann C; Mathé-Allainmat M; Andrieux J; Renard P; Delagrange P; Langlois M
    J Med Chem; 1999 Mar; 42(6):1100-5. PubMed ID: 10090792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-affinity relationships of indole-based melatonin analogs.
    Spadoni G; Mor M; Tarzia G
    Biol Signals Recept; 1999; 8(1-2):15-23. PubMed ID: 10085458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative binding energy analysis of HIV-1 protease inhibitors: incorporation of solvent effects and validation as a powerful tool in receptor-based drug design.
    Pérez C; Pastor M; Ortiz AR; Gago F
    J Med Chem; 1998 Mar; 41(6):836-52. PubMed ID: 9526559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationship of novel benzoxazole derivatives as melatonin receptor agonists.
    Sun LQ; Chen J; Bruce M; Deskus JA; Epperson JR; Takaki K; Johnson G; Iben L; Mahle CD; Ryan E; Xu C
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3799-802. PubMed ID: 15203165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the melatonin receptor. 5. Melatonin agonists and antagonists derived from tetrahydrocyclopent[b]indoles, tetrahydrocarbazoles and hexahydrocyclohept[b]indoles.
    Davies DJ; Garratt PJ; Tocher DA; Vonhoff S; Davies J; Teh MT; Sugden D
    J Med Chem; 1998 Feb; 41(4):451-67. PubMed ID: 9484496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-(2-Alkanamidoethyl)-6-methoxyindole derivatives: a new class of potent indole melatonin analogues.
    Tarzia G; Diamantini G; Di Giacomo B; Spadoni G; Esposti D; Nonno R; Lucini V; Pannacci M; Fraschini F; Stankov BM
    J Med Chem; 1997 Jun; 40(13):2003-10. PubMed ID: 9207941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the structural requirements of the receptor-binding affinity of diphenolic azoles to estrogen receptors alpha and beta by three-dimensional quantitative structure-activity relationship and structure-activity relationship analysis.
    Demyttenaere-Kovatcheva A; Cronin MT; Benfenati E; Roncaglioni A; Lopiparo E
    J Med Chem; 2005 Dec; 48(24):7628-36. PubMed ID: 16302803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New naphthalenic ligands of melatoninergic receptors].
    Adam G; Guardiola-Lemaitre B; Yous S; Lesieur D; Morgan P; Howell HE; Andrieux J; Caignard DH; Pfeiffer B; Renard P
    J Pharm Belg; 1992; 47(4):374-80. PubMed ID: 1328595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands.
    Bedini A; Spadoni G; Gatti G; Lucarini S; Tarzia G; Rivara S; Lorenzi S; Lodola A; Mor M; Lucini V; Pannacci M; Scaglione F
    J Med Chem; 2006 Dec; 49(25):7393-403. PubMed ID: 17149869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reassessing the melatonin pharmacophore--enantiomeric resolution, pharmacological activity, structure analysis, and molecular modeling of a constrained chiral melatonin analogue.
    Rivara S; Diamantini G; Di Giacomo B; Lamba D; Gatti G; Lucini V; Pannacci M; Mor M; Spadoni G; Tarzia G
    Bioorg Med Chem; 2006 May; 14(10):3383-91. PubMed ID: 16431121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSAR analyses of 3-(4-benzylpiperidin-1-yl)-N-phenylpropylamine derivatives as potent CCR5 antagonists.
    Roy K; Leonard JT
    J Chem Inf Model; 2005; 45(5):1352-68. PubMed ID: 16180912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.